
PIONEERING INNOVATION IN COMPLEX MOLECULE MANUFACTURING: A NEW GENERATION OF CDMO SERVICES, BY INDENA
For over a century, Indena has stood as a beacon of research and development

For over a century, Indena has stood as a beacon of research and development

Highly potent active pharmaceutical ingredients (HPAPIs) are no longer a niche. They are at

INDENA SPOTLIGHTS EXPANDED CAPABILITIES AND INNOVATION AT CPHI 2025 FEATURING: NEXT – GENERATION TECHNOLOGIES

THE COMPANIES COMBINE THEIR UNIQUE EXPERTISE TO ACCELERATE THE DEVELOPMENT OF INNOVATIVE, SUSTAINABLE PAYLOAD-LINKERS
Working with HPAPIs brings unique challenges in safety, containment, and scalability; challenges that Indena can face, being a global leader in development and production of high-quality and complex APIs and HPAPIs derived from plants, synthesis, sem

THE ITALIAN COMPANY STANDS AS A RELIABLE PARTNER FOR PHARMA AND BIOTECH CLIENTS IN
Indena is glad to attend CPHI Japan in Tokio 9 – 11 April 2025 and to meet its customers and stakeholders.
The market for HPAPIs is growing due to the increasing prevalence of complex diseases like cancers, autoimmune disorders, infectious diseases and rare diseases.
INDENA DISPLAYS A KEY UNIQUENESS ON HIGHLY POTENT APIS DOWN TO 1 NG/M3 OEL.
THE EXPERTISE INCLUDES PAYLOADS FOR ADCS, WITH A BACKWARD INTEGRATION ON FERMENTATION FOR TOXINS
REQUIRING THIS STEP AND LYOPHILIZATION ABILITY IN HIGH CONTAINMENT
Indena’s Custom Development & Manufacturing Organization services offer a full range of manufacturing capabilities for pharmaceutical ingredients including Active Pharmaceutical Ingredients (APIs). Such services include the extraction, isolation…